Effects of synthetic corticotropin-releasing factor and dopamine on the release of immunoreactive β-endorphin/β-lipotropin and α-melanocyte-stimulating hormone from human fetal pituitaries in vitro

D. M. Gibbs, R. D. Stewart, J. H. Liu, W. Vale, J. Rivier, S. S. Yen

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The effects of synthetic corticotropin-releasing factor (CRF) and dopamine on immunoreactive β-endorphin/β-lipotropin (iβ-END/LPH) and αMSH release were studied in superfused human fetal pituitary glands. CRF (20 ng) stimulated the release of iβ-END/LPH in four anterior hemipituitaries from fetuses older than 20 weeks in gestation. There was no effect on three anterior hemipituitaries from fetuses of 19-20 week gestation. CRF had no effect on iβ-END/LPH or αMSH secretion from neurointermediate lobes regardless of fetal age. Dopamine (10 -6 M) had no effect on iβ-END/LPH or αMSH secretion from either anterior or neurointermediate lobes. The data suggest that anterior pituitary responsiveness to CRF develops at about 20 weeks gestation and that fetal neurointermediate lobe secretion of peptides is not regulated by CRF.

Original languageEnglish (US)
Pages (from-to)1149-1152
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Volume55
Issue number6
StatePublished - 1982

Fingerprint

beta-Lipotropin
Endorphins
Melanocyte-Stimulating Hormones
Corticotropin-Releasing Hormone
Dopamine
Pregnancy
Fetus
Pituitary Gland
Gestational Age
In Vitro Techniques
Peptides

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Effects of synthetic corticotropin-releasing factor and dopamine on the release of immunoreactive β-endorphin/β-lipotropin and α-melanocyte-stimulating hormone from human fetal pituitaries in vitro. / Gibbs, D. M.; Stewart, R. D.; Liu, J. H.; Vale, W.; Rivier, J.; Yen, S. S.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 55, No. 6, 1982, p. 1149-1152.

Research output: Contribution to journalArticle

@article{624fd1b330484d3290dab87de990770c,
title = "Effects of synthetic corticotropin-releasing factor and dopamine on the release of immunoreactive β-endorphin/β-lipotropin and α-melanocyte-stimulating hormone from human fetal pituitaries in vitro",
abstract = "The effects of synthetic corticotropin-releasing factor (CRF) and dopamine on immunoreactive β-endorphin/β-lipotropin (iβ-END/LPH) and αMSH release were studied in superfused human fetal pituitary glands. CRF (20 ng) stimulated the release of iβ-END/LPH in four anterior hemipituitaries from fetuses older than 20 weeks in gestation. There was no effect on three anterior hemipituitaries from fetuses of 19-20 week gestation. CRF had no effect on iβ-END/LPH or αMSH secretion from neurointermediate lobes regardless of fetal age. Dopamine (10 -6 M) had no effect on iβ-END/LPH or αMSH secretion from either anterior or neurointermediate lobes. The data suggest that anterior pituitary responsiveness to CRF develops at about 20 weeks gestation and that fetal neurointermediate lobe secretion of peptides is not regulated by CRF.",
author = "Gibbs, {D. M.} and Stewart, {R. D.} and Liu, {J. H.} and W. Vale and J. Rivier and Yen, {S. S.}",
year = "1982",
language = "English (US)",
volume = "55",
pages = "1149--1152",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Effects of synthetic corticotropin-releasing factor and dopamine on the release of immunoreactive β-endorphin/β-lipotropin and α-melanocyte-stimulating hormone from human fetal pituitaries in vitro

AU - Gibbs, D. M.

AU - Stewart, R. D.

AU - Liu, J. H.

AU - Vale, W.

AU - Rivier, J.

AU - Yen, S. S.

PY - 1982

Y1 - 1982

N2 - The effects of synthetic corticotropin-releasing factor (CRF) and dopamine on immunoreactive β-endorphin/β-lipotropin (iβ-END/LPH) and αMSH release were studied in superfused human fetal pituitary glands. CRF (20 ng) stimulated the release of iβ-END/LPH in four anterior hemipituitaries from fetuses older than 20 weeks in gestation. There was no effect on three anterior hemipituitaries from fetuses of 19-20 week gestation. CRF had no effect on iβ-END/LPH or αMSH secretion from neurointermediate lobes regardless of fetal age. Dopamine (10 -6 M) had no effect on iβ-END/LPH or αMSH secretion from either anterior or neurointermediate lobes. The data suggest that anterior pituitary responsiveness to CRF develops at about 20 weeks gestation and that fetal neurointermediate lobe secretion of peptides is not regulated by CRF.

AB - The effects of synthetic corticotropin-releasing factor (CRF) and dopamine on immunoreactive β-endorphin/β-lipotropin (iβ-END/LPH) and αMSH release were studied in superfused human fetal pituitary glands. CRF (20 ng) stimulated the release of iβ-END/LPH in four anterior hemipituitaries from fetuses older than 20 weeks in gestation. There was no effect on three anterior hemipituitaries from fetuses of 19-20 week gestation. CRF had no effect on iβ-END/LPH or αMSH secretion from neurointermediate lobes regardless of fetal age. Dopamine (10 -6 M) had no effect on iβ-END/LPH or αMSH secretion from either anterior or neurointermediate lobes. The data suggest that anterior pituitary responsiveness to CRF develops at about 20 weeks gestation and that fetal neurointermediate lobe secretion of peptides is not regulated by CRF.

UR - http://www.scopus.com/inward/record.url?scp=0020460689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020460689&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 1149

EP - 1152

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -